Patient-Reported Outcomes in Patients With PIK3CA -Mutated Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer From SOLAR-1
Ciruelos, Eva Maria, Rugo, Hope S, Mayer, Ingrid A, Levy, Christelle, Forget, Frédéric, Delgado Mingorance, Juan Ignacio, Safra, Tamar, Masuda, Norikazu, Park, Yeon Hee, Juric, Dejan, Conte, Pierfranco, Campone, Mario, Loibl, Sibylle, Iwata, Hiroji, Zhou, Xiaolei, Park, Jinhee, Ridolfi, Antonia, Lorenzo, Ines, André, Fabrice
Published in Journal of clinical oncology (20.06.2021)
Published in Journal of clinical oncology (20.06.2021)
Get full text
Journal Article
Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16)
Gillessen, Silke, Procopio, Giuseppe, Hayoz, Stefanie, Kremer, Eloïse, Schwitter, Michael, Caffo, Orazio, Lorente, David, Pedrazzini, Augusto, Roubaud, Guilhem, Nenan, Soazig, Omlin, Aurelius, Buttigliero, Consuelo, Delgado Mingorance, Juan Ignacio, González-Del-Alba, Aránzazu, Delgado, Maria Teresa, Nole, Franco, Turco, Fabio, Pereira Mestre, Ricardo, Ribi, Karin, Cathomas, Richard
Published in Journal of clinical oncology (10.07.2023)
Published in Journal of clinical oncology (10.07.2023)
Get full text
Journal Article
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study
Feliu, Jaime, Jorge Fernández, Mónica, Macarulla, Teresa, Massuti, Bartomeu, Albero, Ana, González González, José Federico, Quintero-Aldana, Guillermo, Delgado-Mingorance, Juan Ignacio, Fernández Montes, Ana, García Piernavieja, Carmen, Valladares-Ayerbes, Manuel, López Muñoz, Ana María, Mondéjar Solís, Rebeca, Vicente, Pilar, Casado Gonzalez, Esther, González Cebrián, Irene, López-Vivanco, Guillermo
Published in Cancer chemotherapy and pharmacology (01.04.2021)
Published in Cancer chemotherapy and pharmacology (01.04.2021)
Get full text
Journal Article
The importance of early identification of infusion-related reactions to monoclonal antibodies
Cáceres, Macarena C, Guerrero-Martín, Jorge, Pérez-Civantos, Demetrio, Palomo-López, Patricia, Delgado-Mingorance, Juan Ignacio, Durán-Gómez, Noelia
Published in Therapeutics and clinical risk management (01.01.2019)
Published in Therapeutics and clinical risk management (01.01.2019)
Get full text
Journal Article
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial
Salvador Bofill, Javier, Moreno Anton, Fernando, Rodriguez Sanchez, Cesar Augusto, Galve Calvo, Elena, Hernando Melia, Cristina, Ciruelos Gil, Eva Maria, Vidal, Maria, Jiménez-Rodriguez, Begoña, De la Cruz Merino, Luis, Martínez Jañez, Noelia, Villanueva Vazquez, Rafael, de Toro Salas, Ruben, Anton Torres, Antonio, Alvarez Lopez, Isabel Manuela, Gavila Gregori, Joaquin, Quiroga Garcia, Vanesa, Vicente Rubio, Elena, De la Haba-Rodriguez, Juan, Gonzalez-Santiago, Santiago, Diaz Fernandez, Nieves, Barnadas Molins, Agusti, Cantos Sanchez de Ibargüen, Blanca, Delgado Mingorance, Juan Ignacio, Bellet Ezquerra, Meritxell, de Casa, Sonia, Gimeno, Asuncion, Martin, Miguel
Published in Breast (Edinburgh) (01.12.2022)
Published in Breast (Edinburgh) (01.12.2022)
Get full text
Journal Article
Circulating tumor cells (CTCs) in patients with HER2-negative recurrent or metastatic breast cancer treated with eribulin as third-line therapy: ONSITE trial (OncoSur Analysis of the Treatment in Third Line of ABC with Eribulin)
Manso, Luis, Moreno, Fernando, Delgado Mingorance, Juan Ignacio, Echarri, Maria Jose, Lopez-Gonzalez, Ana, Izarzugaza, Yann, Borrega, Pablo, Martínez, Noelia, Olier, Clara, Ballesteros Garcia, Ana Isabel, Chacon, Jose Ignacio, Ciruelos, Eva, Pascual, Tomas, Paz-Ares, Luis
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article